$GBS Bio stock Real-time Saliva Glucose & Saliva SARS-CoV-2 Antibody test Eliminates finger pricks and blood tests Large cash runway through most of 2022 Oversold Low Float
Upcoming earnings estimated November 11, 2021. Disney's FY 20 revenue was distributed as follows: 28.39B Digital Media 16.5B Parks, Experiences and Products 9.64B Studio Entertainment 16.97B Direct-to-consumer and International sales Digital Media generated nearly 40% of total revenue and double any other source of revenue. The revenue during the...
$CHGG Closing above trendline sets this up for a large move to the upside and a long-term bullish trend reversal. Earnings expected around August 09, 2021. Missed last earnings for the first time since 2017. A positive earnings could send this on an aggressive uptrend.
$PTON Looking for a close above longer term trendline. This will allow us to continue the uptrend in the channel and set us up for a longer term move to the upside. Upcoming earnings expected mid September.
$POSH Beat previous earnings. Setting up for big move on larger timeframe. Lockup agreement expires around July 13, 2021. Likely see this continue down until lockup expires and steadily climb back up thorough earnings around August 11, 2021. Low float, high short and high rel vol
$WISH I usually avoid MEME stocks but it's hard to ignore this setting up nicely to run. Watching for retest of $15.45 area resistance. Working it's way up the trendline, at a strong area of contention. Closing above $15.45 will send it with 20/50 SMA crossover as confirmation.
$SABR New & renewed partnerships. $1.3billion cash. Travel restrictions easing. TSA screening nearly 5x travelers vs 2020. Anticipating a steady uptrend. 200 EMA bolstering trendline & support. 19% short-float, rel vol increasing and becoming oversold. www.tsa.gov
$IDRA Recent insider buying, a bullish indication. Big news may be released soon. Mutli-phase trials of Tilsotolimod. ILLUMINATE-206 phase 2 results expected soon. Low float and high rel vol w/ a large gap to fill.
$CPRT Retesting a strong resistance with increasing volume. We could likely see a breakout soon and leg up to a new ATH. Beat previous quarter earnings by over 36%. Will be watching this one closely
$TLMD Telemedicine. Cash from recent public offering at $5.65. Becoming oversold in an area of high liquidity. Relatively low float and over 4XRel Vol! Could move quickly when it runs. Underwriters forfeit their right to acquire additional shares at offering price after next week
$KOPN 20+50 SMA bullish crossover. Support bolstered by the 50 EMA. 1.5 Rel Vol In an area of liquidity. Added to Russell 2000 June 28. New government orders. Successfully developing Super-Compact, Lightweight, Stylish all-plastic Pancake VR Glasses. www.kopin.com
$STEM MOU w/ CleanCapital granting financing partnership & first refusal rights for new and retrofit solar PV opportunities. Altus Power America agreement to Provide Energy Storage to Massachusetts Solar Project. 2xRel. Vol. Looking ready to fill the gap. investors.stem.com
$ZNGA Technical play. Big move expected soon. Currently finding support on the 50 EMA , 200 EMA riding bottom of wedge and approaching the point of control. Earnings August 4, 2021. Breaking $11 opens us up to ATH. Low rel vol and currently under analysts price targets.
$NFLX Filling a wedge at a strong area of contention. Area of resistance is bolstered by the 50 & 200 EMA. Breaking above would give us room to fill the gap and move us into a longer term uptrend.
$HIMX Consecutive inside days. Dividend paid July 12. Riding the top trend line., low rel vol. A Break above $14.60 opens us to $15.50 and ATH of $17.88. Point of control at the $13 horizontal support bolstered by the 21 EMA.
$PRPL Outperformed in their most recent Q1 earnings. Great technical setup, Once we break over this resistance, we also break over the 200 EMA which should give a lot more confidence to potential investors and volume should start an uptrend. Under analysts PT
$COUP Analysts didn't seem to react well to earnings but their YOY growth is impressive and forward-looking I expect a lot more upside from here. The relative volume is elevated and current volume increasing. We break $245 this will gain steam and fast.
$EVFM Bio play. Over 14% short-float. Testing the 50 EMA at an area of resistance. We need to break over $1.40 and this could really fly. Lot's of recent insider buying and Large stake by Morgan Stanley. EVO100 Phase 3, Fast track approval. Results expected 2022. Expecting $3+.